Viewpoint: Amyloid-targeting New Therapies for Alzheimer's Disease: A Health Economics Perspective
J Prev Alzheimers Dis
.
2023;10(2):349-352.
doi: 10.14283/jpad.2023.76.
Authors
L Jönsson
1
,
A Wimo
Affiliation
1
Anders Wimo, Section for Neurogeriatrics, Department for Neurobiology, Care Sciences and Society, Karolinska Institute, Sweden, anders.wimo@ki.se.
PMID:
37357271
DOI:
10.14283/jpad.2023.76
No abstract available
MeSH terms
Alzheimer Disease* / drug therapy
Amyloid
Amyloid beta-Peptides
Humans
Substances
Amyloid beta-Peptides
Amyloid